US EditionPublished • loading... • Updated
Prohibition and Removal of Batches of Physiological Solution Rigecin Due to Quality Defects
Summary by Noticias Argentinas | Agencia De Noticias
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The National Administration of Medicines, Food and Medical Technology (ANMAT) ordered the prohibition of the use, distribution and marketing throughout the country of two batches of the “Isotónica Physiological Solution Rigecin 0.90%”, produced by Rigecin Labs S.A., following a quality deviation considered “critical” and with a high impact on health. The provision affects lots NA5187 S2 (survey 01/2027) and NA5675 S1 (survey 04/2027), which pres…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
